Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
Throughout its years of rapid growth, Actelion has always been highly conscious of the fact that it is its own people who make the difference.
Actelion was founded on 17 December 1997 and is now a public listed company on the Swiss stock exchange (SIX).
"I firmly believe that corporate responsibility is part of the everyday management of a successful business.”
Jean-Paul Clozel, CEO
